Genetic variants in the brain-derived neurotrophic factor (BDNF) gene, predominantly the functional Val66Met polymorphism, have been associated with risk of bipolar disorder and other psychiatric disorders. However, not all studies support these findings, and overall the evidence for the association of BDNF with disease risk is weak. As differences in population genetic structure between patient samples could cause discrepant or spurious association results, we investigated this possibility by carrying out population genetic analyses of the BDNF genomic region. Substantial variation was detected in BDNF coding region singlenucleotide polymorphism (SNP) allele and haplotype frequencies between 58 global populations, with the derived Met allele of Val66Met ranging in frequency from 0 to 72% across populations. F ST analyses to assess diversity in the HapMap populations determined that the Val66Met F ST value was at the 99.8th percentile among all SNPs in the genome. As the BDNF population genetic differences may be due to local selection, we performed the longrange haplotype test for selection using 68 SNPs spanning the BDNF genomic region in 12 European-derived pedigrees. Evidence for positive selection was found for a high-frequency Val-carrying haplotype, with a relative extended haplotype homozygosity value above the 99th percentile compared with HapMap data (P = 4.6 Â 10
Introduction
Brain-derived neurotrophic factor (BDNF) is a key neurotrophic factor important for neuronal development, survival and plasticity.
1,2 A non-synonymous polymorphism in BDNF that leads to a valine-tomethionine change at position 66 of the proBDNF protein, referred to as Val66Met, has been shown to have an important role in neuronal and cognitive function. [3] [4] [5] [6] [7] [8] [9] [10] BDNF is implicated as a genetic risk factor for several psychiatric disorders. We reported earlier the over-representation of the Val allele of the Val66Met polymorphism and the lower frequency of a Met-carrying haplotype in BP patients. 11 The association of Val66Met with BP has received mixed support in subsequent studies (Supplementary Table S1 ). A meta-analysis that we performed using data from 14 case-control and parent-proband trio studies detected modest but statistically significant evidence for the association of BDNF with BP (P = 0.004). 12 BDNF variants have also been associated with other psychiatric disorders, including obsessive-compulsive disorder, [13] [14] [15] schizophrenia, [16] [17] [18] [19] psychosis, 20 major depression, 21 anxiety 22 and eating disorders. [23] [24] [25] [26] Lack of association has also been reported for many of these disorders, however, raising the question of whether BDNF is in fact a disease susceptibility gene. One explanation for discrepant association findings is the differences in population genetic structure between patient samples. Isolation between human populations over generations has resulted in genetic differentiation marked by allele frequency and linkage disequilibrium (LD) differences. Thus, a single population may not accurately reflect variation in other populations, and within the same population, some members may not be representative of others. Such differences could have a profound impact on the detection of disease risk genes because association studies examine a fraction of gene polymorphisms and rely extensively on LD between markers and susceptibility alleles to detect disease associations. Furthermore, if LD patterns vary dramatically between groups, population-specific haplotypes will arise that could explain conflicting association results. Thus, an assessment of the distribution of polymorphic markers and haplotypes worldwide is necessary to accurately interpret disease association data from different patient populations.
We therefore performed a population genetic study of the BDNF genomic region to determine whether population dynamics could explain the inconsistent psychiatric association findings. Our data provide evidence for substantial population diversity at the BDNF locus, as well as the two putative selection events acting on BDNF alleles, which have significant implications for disease association studies of this gene.
Materials and methods

Subjects
The study received approval from all appropriate Institutional Review Boards. DNA from the following collections was utilized: 12 multiplex pedigrees (93 individuals) obtained from the Centre d'Etudie Polymorphisme Humain (CEPH) repository, 27 ,28 the HGDR-CEPH Human Genome Diversity Cell Line Panel consisting of 1064 individuals from 57 world-wide populations 29 and 31 parent-child trios from the Yoruba people of Ibadan, Nigeria. The CEPH sample overlaps with the HapMap European (CEU) sample by 50%. 30 
SNP genotyping
Single-nucleotide polymorphisms (SNPs) were selected from the dbSNP database (http://www.ncbi.nlm.nih. gov/SNP/), from our earlier study, 11 and from the former Celera Discovery System database. Genotyping was performed by Sequenom MassARRAY (San Diego, CA, USA) mass spectrometry as described earlier.
11 SNP genotype data were subjected to the following quality control criteria before analyses: (1) > 86% of attempted genotypes were successful (average 97% CEPH, > 99% HGDR panel and 98% Yoruban), (2) founder alleles were in Hardy-Weinberg equilibrium (goodness-of-fit test P > 0.05), (3) < 2% of transmitted alleles had Mendelian inheritance errors and (4) had a minor allele frequency > 2%.
Haplotype genealogy and global diversity Twelve SNPs within the BDNF coding region were genotyped in the HGDR-CEPH Human Diversity Panel, 31 Yoruban parent-child trios and 12 CEPH pedigrees. SNP identifiers are provided in Supplementary Table S2 . Maximum-likelihood expectation haplotypes comprising the SNPs were reconstructed using an expectation-maximization algorithm using data from all populations together to minimize artifact separation of the populations. SNP ancestral alleles were predicted from consensus genotypes from chimpanzee, gorilla and orangutan DNA. Haplotype frequencies were determined for African, Asian and European continental groups using all chromosomes that could be definitively classified into one of the groups (364 African, 444 Asian and 418 European chromosomes).
The Sweep program (P Varilly, B Fry and P Sabeti; http://www.broad.mit.edu/mpg/sweep/) was used to create BDNF haplotype genealogical trees for the three major continental regions using all classifiable chromosomes. A map of global diversity of BDNF haplotypes was created by displaying pie charts representing the calculated haplotype frequencies for each population on a world map using the Diaspora software program (B Fry, unpublished software). Fixation index (F ST ) values to assess population differentiation were calculated using the Weir-Hill unbiased estimator 31 for SNPs that were polymorphic in at least one population in the HapMap Phase II (release 21) data set. 32 Population comparisons were performed by calculating F ST values separately for the HapMap European (CEU), African (Yoruban-YRI) and Asian (Chinese and Japanese-CHB/JPT) populations. Significance of the F ST values was determined by comparison with HapMap data.
Long-range haplotype test
The long-range haplotype (LRH) test 33 was used to examine evidence for the recent positive selection at BDNF. Genotype data were utilized from 68 SNPs (Supplementary Table S2 ) spanning 500 kb of the BDNF genomic region genotyped in 12 CEPH pedigrees, as well as genotype data from the International HapMap Project data release 16. 30 Haplotype blocks were defined according to Gabriel et al. 34 Maximumlikelihood expectation haplotypes were reconstructed using an expectation-maximization algorithm. The LRH test detects the evidence of an allele's recent and rapid rise in prevalence in a population, based on the disparity in the allele age estimated from its high frequency (characteristic of an old allele) and its longrange LD (characteristic of a young allele). Long-range association was measured by extended haplotype homozygosity (EHH). 33 For a population of individuals sharing allele 't', EHH at a distance 'x' from the locus is the probability that two random chromosomes carrying the allele are identical by descent for the entire interval from the locus to 'x'. Correction for local variation in recombination rates was performed using the relative EHH (REHH), the factor by which EHH decays on the tested allele compared with all other alleles at a locus. The REHH and EHH were corrected by matching genetic distances of the loci using recombination rates from HapMap data. Decay of the extended ancestral haplotype on which the tested allele arose was visualized using the Bifurcator program (B Fry; http://benfry.com/bifurcator/).
Results
Global diversity of BDNF SNPs
Analysis of BDNF diversity focused on the Val66Met polymorphism (rs6265) and 11 other SNPs within the BDNF coding region that together encompass the region containing all BDNF variants reported to be associated with BP (Val66Met, a functional repeat polymorphism located 1 kb upstream of exon 5, 35, 36 and a coding region haplotype 11 ). All 
Global diversity of BDNF haplotypes
We subsequently examined population diversity of haplotypes comprised of the 12 BDNF SNPs. Eleven haplotypes that were observed at a frequency above 2% in at least one of the European, Asian and SubSaharan African continental groups had clear frequency differences between the three groups ( Figure  2a and Supplementary Table S3 ). Met66 ('T' allele) was present on two haplotypes, each exclusive to Asia and Europe (haplotype-6 and -7, respectively), and was not present on any Sub-Saharan African haplotypes. Haplotype-7 corresponds to the Met66-carrying haplotype we earlier found associated with BP.
11
BDNF haplotype genealogical trees were constructed for each of the continental groups to clarify the population genetic structure (Figure 2b) . The number and length of branches in the three trees were comparable, indicating a similar history and mutational distance from the ancestral haplotype. An exception was the branch that contains haplotype-6 or -7 in the Asian or European tree, respectively, which was shorter in the African tree due to having only one haplotype (haplotype-2). Haplotype-6 was found to be ancestral to haplotype-7, differing only in the allele of rs2049045 (of the SNPs we examined), with haplotype-6 having the ancestral 'G' allele and haplotype-7 having the derived 'C' allele (Figure 2a) .
Examination of BDNF haplotypes among the global populations identified considerably different haplotype structure and frequencies between populations, but generally similar patterns within a geographical group (Figure 2c and Supplementary Table S3 ). Of the Met66-carrying haplotypes, the frequency of haplotype-6 ranged from 2 to 70% in Asian, Oceanian, and some Central and South American populations, whereas haplotype-7 was at 2-29% frequency in European, North African, Middle Eastern and some Asian (solely Pakistani) populations. All together, these data further point toward the considerable diversity of BDNF polymorphisms among worldwide populations.
Evidence for positive selection of haplotypes spanning the BDNF region The observed population genetic differences in BDNF alleles may be due to local selection, which can have large effects on LD and thereby impact association studies. We therefore looked for evidence of selection across the BDNF genomic region within Europeanderived CEPH pedigrees using the LRH test. 33 This method detects evidence for a more recent positive selection event ( < 30 000 years old) compared with the F ST analyses above. The LRH test identifies variants that appear to have recently arisen in a population, based on the extent of the surrounding ancestral chromosome, but that are prevalent in the population, suggesting that natural selection may have caused a rapid rise in the allele's frequency.
We examined 68 SNPs across a 500-kb region on chromosome 11, spanning the BDNF, LIN7C, LGR4 and CCDC34 genes. A common 45% frequency haplotype located 5 0 of BDNF had evidence for an extended ancestral haplotype, as measured by relative REHH (see Materials and methods). The long-range haplotype extending from this haplotype covers the entire genomic region examined (Supplementary Figure S1A) . The haplotype carries the Val66 allele and corresponds to haplotype-11 in Figure 2 . Further evidence for the selection of the BDNF haplotype was obtained by comparison of its REHH and frequency with the empirical distribution of chromosome 11 haplotypes from the HapMap European (CEU) data. 30 The haplotype REHH value was above the 99th percentile when compared with 1652 chromosome 11 haplotypes with comparable frequencies (40-45%) (Supplementary Figure S1B ; uncorrected P = 4.6 Â 10
À4
). This result indicates that the haplotype has more extensive LD, given its frequency, than expected under neutrality, which is suggestive of selection at the BDNF genomic region. Selection on this Val66-carrying haplotype is unlikely to explain the high Val66Met F ST values above, as the elevated Met allele frequency outside of Africa appears to drive the F ST result.
Discussion
Our study to gain an insight into the potential impact of population diversity on association studies of BDNF revealed several lines of evidence that suggest that the BDNF genomic region is not neutrally evolving. First, prominent differences were found among global populations in frequencies of the Val66Met variant and BDNF haplotypes. The derived Met66 allele ranged in frequency considerably from 0 to 72% across populations, and exists on different population-specific haplotypes in Europeans and Asians. This substantial global diversity was supported by F ST analyses in the HapMap populations, in which the Val66Met F ST value was above the 99th percentile in the distribution of all SNPs in the genome. This putative selection signal appears to be driven by the derived Met allele and reflects its rise in frequency across Sub-Saharan African, European and Asian populations. Second, the presence of young polymorphisms at a high frequency in Europeanderived populations is indicative of a more recent selection event. A long-range haplotype detected at the BDNF locus carries the Val allele of Val66Met, and thus appears to be a different selection event than the Met allele signal identified in F ST analyses. These data suggest that selection may have been operating on more than one BDNF allele or haplotype. It is important to note, however, that due to extensive LD, the long-range haplotype extends throughout the entire region examined, spanning BDNF, LIN7C, LGR4
and CCDC34, and it is therefore not possible to distinguish from which gene this selection event originates. Given the critical functions of BDNF in neuronal survival and plasticity, 1,2 selection may increase the prevalence of new variants that increase fitness by altering any of these functions.
The global diversity of Met66 and its rapid rise across Sub-Saharan African, European and Asian populations is intriguing given its seemingly detrimental effect on neuronal and cognitive function. [4] [5] [6] [7] [8] [9] [10] In addition, Met66 is at a lower frequency in BP and other psychiatric patients compared with that in controls (except in eating disorders), rather than at a higher frequency as expected, given its apparently deleterious function. As BDNF has diverse roles in neural development, cell survival and synaptic plasticity, 1,2 it is possible that Met66 has pleiotropic effects, some detrimental and some beneficial. As discussed by Lipsky and Marini, 2 downregulation of synaptic plasticity by Met66, particularly in excitatory glutamatergic circuits, may be protective against psychiatric disorders, despite Met66 being associated with a reduced cognitive performance. 4, [6] [7] [8] [9] [10] The observed population genetic differences in BDNF have implications for interpreting the conflicting association literature for psychiatric disorders. If Val66Met is a true risk variant, its presence on different haplotypic backgrounds may produce different association patterns in different populations, which could account for the inconsistent association signals between studies. Alternatively, if Val66Met does not have a direct role in disease, but rather is in LD with the true associated allele to varying degrees in different populations, inconsistent association findings with Val66Met could also result due to population differences in LD patterns. It will be crucial to consider population genetic information when carrying out future disease association studies of this locus.
In conclusion, we have uncovered substantial global diversity and evidence for positive selection of the BDNF Val66Met polymorphism and BDNF region haplotypes. The unusual genetic diversity at the locus may explain the varying results between earlier association studies using different patient populations. Further studies that take into account the population diversity in the BDNF genomic region are required to elucidate whether this gene has a role in major mental illness. from the National Alliance on Schizophrenia and Depression (TLP and JBF), and a Burroughs Wellcome Career Award in the Biomedical Sciences (PCS).
